GoKawiilHBO documentary on Elizabeth Holmes reignites scrutiny of diagnostics industry
A new HBO film, 'You Can See Everything', covers the weeks before Elizabeth Holmes began her prison sentence in 2023 for defrauding investors in her blood-testing startup Theranos. More than a decade after Theranos collapsed, diagnostics companies developing similar low-volume blood testing devices say they are still dealing with the aftermath of its fraud.
GoKawiil's interpretation of the reporting above, not reported fact.
The renewed attention suggests Theranos remains a reference point that investors and researchers use to judge credibility in diagnostics, according to industry figures quoted. Executives like Truvian Health's Dena Marrinucci frame this as a lesson about earning trust through evidence rather than claims, which could continue to shape how new blood-testing firms pitch and validate their technology.
- HBO's 'You Can See Everything' has renewed public interest in the Theranos scandal since its US release.
- Diagnostics researchers say Theranos's fraud left lasting skepticism toward blood-testing innovation.
- Industry figures argue that evidence-based validation, not bold claims, is now essential to rebuilding trust in the sector.
Source: nature.com — Glickman, 2026-10-23
Published there as: “Elizabeth Holmes film enthralls — but her legacy haunts science”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.